한글목차

혈장 단백질 치료제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 346억 8,000만 달러에서 2026년에는 370억 9,000만 달러에 이르고, CAGR 6.9%로 성장할 전망입니다. 지난 수년간의 성장에는 원발성 면역결핍증 유병률 증가, 면역글로불린 요법에 대한 수요 증가, 혈장 제공 인프라의 한계, 단백질 정제 기술의 발전, 혈장 유래 요법의 규제 승인 등이 주요 요인으로 꼽힙니다.

혈장 단백질 치료제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 489억 8,000만 달러에 이르고, CAGR은 7.2%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 재조합 알부민 및 응고인자의 성장, 피하 투여 방법의 확대, 신흥 시장에서의 의료비 지출 증가, 정밀의료의 기술 발전, 혈장 수집을 위한 민관 협력 증가 등을 들 수 있습니다. 예측 기간 동안 주요 동향으로는 맞춤형 혈장 단백질 치료법 개발, 재조합 단백질 생산 확대, 피하 투여법 채택 증가, 희귀 혈액 질환에 대한 인식 제고, 공급망 및 콜드체인 물류 강화 등이 있습니다.

향후 몇 년 동안 자가면역질환의 유병률 증가가 혈장단백질 치료제 시장의 성장을 견인할 것으로 예측됩니다. 자가면역질환은 우리 몸의 면역체계가 건강한 세포를 잘못 공격하고 손상시켜 발생합니다. 치료용 혈장교환요법은 신체를 공격하는 자가항체 생산을 조절하는 데 도움이 되기 때문에 이러한 질환을 치료하는 데 사용됩니다. 예를 들어, 2023년 5월 영국 공립대학인 글래스고 대학에서 실시한 연구에 따르면, 자가면역질환이 영국 인구의 약 10%에 영향을 미치고 있으며, 이는 2022년 추정치를 상회하는 것으로 나타났습니다. 그 결과, 자가면역질환의 유병률 증가가 혈장단백질 치료제 시장의 성장에 기여하고 있습니다.

혈장 단백질 치료제 시장의 주요 기업들은 응급의료 및 병원 전 의료 현장에서 휴대성, 안정성, 신속성을 갖춘 혈액제제에 대한 수요 증가에 대응하기 위해 동결건조 혈장제제 등 혁신적인 솔루션 개발에 주력하고 있습니다. 동결건조 혈장 제품은 기존 동결혈장에 비해 보존기간 연장, 보관 용이성, 신속한 재구성을 가능하게 하는 동결건조 제제입니다. 이러한 특성으로 인해 외상 치료, 응급 의료, 야외 환경에서 사용하기에 매우 적합합니다. 예를 들어, 2023년 10월 스위스에 본사를 둔 제약회사 옥타파마(Octapharma AG)는 자사 제품인 옥타플러스 LG의 동결건조 버전에 대해 유럽 의료 당국의 승인을 받았습니다. 이 첨단 제형은 응급상황에서 수혈을 용이하게 하고, 응급치료 상황에서 신속한 가용성, 간소화된 취급 및 향상된 안정성을 제공합니다. 이 제품은 외상 및 출혈성 응급상황을 효과적으로 관리할 수 있도록 지원하며, 혁신적인 혈장 기반 치료법을 통해 환자 치료를 개선하고자 하는 옥타파마의 의지를 반영합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Plasma protein therapeutics refers to treatments derived from plasma and their recombinant analogs. These therapies are used to treat specific medical conditions by replacing missing or deficient proteins found in plasma, enabling recipients to lead healthier and more productive lives.

The main products in plasma protein therapeutics include immunoglobulin, albumin, coagulation factors, C1-esterase inhibitors, and other related products. Immunoglobulin is a component of blood plasma that contains immunoglobulins or antibodies. These therapies are administered through various routes, including intravenous and subcutaneous, and are used to treat a range of conditions such as primary immunodeficiency disorder (PID), idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and other medical applications.

Tariffs have influenced the plasma protein therapeutics market by increasing import costs of raw plasma and recombinant proteins, affecting overall production expenses. Segments such as immunoglobulin and coagulation factors, particularly in regions like Europe and Asia-Pacific, are most impacted due to reliance on imports. While tariffs have slowed supply chain operations, they have encouraged local plasma collection initiatives and domestic manufacturing expansion, providing opportunities for market growth and innovation in cost-effective production.

The plasma protein therapeutics market research report is one of a series of new reports from The Business Research Company that provides plasma protein therapeutics market statistics, including plasma protein therapeutics industry global market size, regional shares, competitors with a plasma protein therapeutics market share, detailed plasma protein therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the plasma protein therapeutics industry. This plasma protein therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma protein therapeutics market size has grown strongly in recent years. It will grow from $34.68 billion in 2025 to $37.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of primary immunodeficiency disorder, rising demand for immunoglobulin therapies, limited plasma donation infrastructure, advances in protein purification technologies, regulatory approvals for plasma-derived therapies.

The plasma protein therapeutics market size is expected to see strong growth in the next few years. It will grow to $48.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growth in recombinant albumin and coagulation factors, expansion of subcutaneous administration methods, increasing healthcare expenditure in emerging markets, technological advancements in precision medicine, rising public-private collaborations for plasma collection. Major trends in the forecast period include personalized plasma protein therapy development, expansion of recombinant protein production, increasing adoption of subcutaneous administration, growing awareness of rare blood disorders, enhanced supply chain and cold chain logistics.

The rising prevalence of autoimmune disorders is expected to drive the growth of the plasma protein therapeutics market in the coming years. Autoimmune disorders occur when the body's immune system mistakenly attacks and damages healthy cells. Therapeutic plasma exchange is used to treat these conditions, as it helps manage the production of autoantibodies that attack the body. For example, in May 2023, a study by the University of Glasgow, a UK-based public university, found that autoimmune disorders affect about 10% of the UK's population, surpassing previous estimates made in 2022. As a result, the increasing prevalence of autoimmune disorders is contributing to the growth of the plasma protein therapeutics market.

Leading companies in the plasma protein therapeutics market are focusing on developing innovative solutions, such as lyophilized plasma formulations, to meet the rising demand for portable, stable, and rapid-use blood products in emergency and pre-hospital care settings. Lyophilized plasma products are freeze-dried formulations that offer extended shelf life, easier storage, and quicker reconstitution compared to traditional frozen plasma. This makes them highly suitable for trauma, emergency medicine, and field environments. For instance, in October 2023, Octapharma AG, a Switzerland-based pharmaceutical company, received approval from European medical authorities for the lyophilized version of its octaplasLG product. This advanced formulation enables convenient pre-hospital transfusions, offering rapid availability, simplified handling, and enhanced stability for critical care situations. The product supports effective management of trauma and bleeding emergencies, reflecting Octapharma's commitment to advancing patient care through innovative plasma-based therapies.

In June 2025, Grifols, a Spain-based provider of plasma-derived therapeutics, acquired Biotest AG for an undisclosed amount. This acquisition aimed to give Grifols full control over Biotest's plasma-protein therapeutic portfolio, streamline operations, and strengthen its market position in the industry. Biotest AG, a Germany-based company, provides plasma-derived therapies such as immunoglobulins, coagulation factors, and specialty plasma proteins.

Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG

North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plasma protein therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasma protein therapeutics market includes revenues earned by entities by providing therapy for liver disease and bleeding from trauma by using Alpha-1 Proteinase Inhibitors, Hyperimmune Globulins. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Protein Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plasma protein therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma protein therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plasma protein therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Immunoglobulin; Albumin; Coagulation Factor; C1-esterase Inhibitors; Other Products
• 2) By Route Of Administration: Intravenous; Subcutaneous
• 3) By Applications: Primary Immunodeficiency Disorder (PID); Idiopathic Thrombocytopenic Purpura; Secondary Immunodeficiency; Hereditary Angioedema; Other Applications
• Subsegments:
• 1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
• 2) By Albumin: Human Serum Albumin; Recombinant Albumin
• 3) By Coagulation Factor: Factor VIII; Factor IX; Prothrombin Complex Concentrates
• 4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors; Recombinant C1-Esterase Inhibitors
• 5) By Other Products: Fibrinogen; Alpha-1 Antitrypsin; Clotting Factor Concentrates
• Companies Mentioned: CSL Behring LLC; Grifols SA; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Baxter International Inc.; Kedrion SpA; LFB SA; Emergent BioSolutions Inc.; Reliance Life Sciences Private Limited; ADMA Biologics Inc.; Prothya Biosolutions BV; Bio Products Laboratory Ltd.; Biotest AG; Taibang Biological Group Co Ltd; Octapharma Plasma Inc.; Green Cross Corporation; China National Biotec Group Company Limited; Kamada Ltd.; Shire PLC; Octapharma AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Plasma Protein Therapeutics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Plasma Protein Therapeutics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Plasma Protein Therapeutics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Plasma Protein Therapeutics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Personalized Plasma Protein Therapy Development
  • 4.2.2 Expansion Of Recombinant Protein Production
  • 4.2.3 Increasing Adoption Of Subcutaneous Administration
  • 4.2.4 Growing Awareness Of Rare Blood Disorders
  • 4.2.5 Enhanced Supply Chain And Cold Chain Logistics

5. Plasma Protein Therapeutics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Blood Banks & Plasma Centers
• 5.4 Research & Diagnostic Laboratories
• 5.5 Home Healthcare Providers

6. Plasma Protein Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plasma Protein Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Plasma Protein Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Plasma Protein Therapeutics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Plasma Protein Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Plasma Protein Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plasma Protein Therapeutics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plasma Protein Therapeutics Market Segmentation

• 9.1. Global Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
• 9.2. Global Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intravenous, Subcutaneous
• 9.3. Global Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications
• 9.4. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
• 9.5. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Serum Albumin, Recombinant Albumin
• 9.6. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Coagulation Factor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Factor VIII, Factor IX, Prothrombin Complex Concentrates
• 9.7. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of C1-Esterase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
• 9.8. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

10. Plasma Protein Therapeutics Market Regional And Country Analysis

• 10.1. Global Plasma Protein Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Plasma Protein Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plasma Protein Therapeutics Market

• 11.1. Asia-Pacific Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plasma Protein Therapeutics Market

• 12.1. China Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plasma Protein Therapeutics Market

• 13.1. India Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plasma Protein Therapeutics Market

• 14.1. Japan Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plasma Protein Therapeutics Market

• 15.1. Australia Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plasma Protein Therapeutics Market

• 16.1. Indonesia Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plasma Protein Therapeutics Market

• 17.1. South Korea Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plasma Protein Therapeutics Market

• 18.1. Taiwan Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plasma Protein Therapeutics Market

• 19.1. South East Asia Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plasma Protein Therapeutics Market

• 20.1. Western Europe Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plasma Protein Therapeutics Market

• 21.1. UK Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plasma Protein Therapeutics Market

• 22.1. Germany Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plasma Protein Therapeutics Market

• 23.1. France Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plasma Protein Therapeutics Market

• 24.1. Italy Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plasma Protein Therapeutics Market

• 25.1. Spain Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plasma Protein Therapeutics Market

• 26.1. Eastern Europe Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plasma Protein Therapeutics Market

• 27.1. Russia Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plasma Protein Therapeutics Market

• 28.1. North America Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plasma Protein Therapeutics Market

• 29.1. USA Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plasma Protein Therapeutics Market

• 30.1. Canada Plasma Protein Therapeutics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plasma Protein Therapeutics Market

• 31.1. South America Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plasma Protein Therapeutics Market

• 32.1. Brazil Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plasma Protein Therapeutics Market

• 33.1. Middle East Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plasma Protein Therapeutics Market

• 34.1. Africa Plasma Protein Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Plasma Protein Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plasma Protein Therapeutics Market Regulatory and Investment Landscape

36. Plasma Protein Therapeutics Market Competitive Landscape And Company Profiles

• 36.1. Plasma Protein Therapeutics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Plasma Protein Therapeutics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Plasma Protein Therapeutics Market Company Profiles
  • 36.3.1. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Grifols SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Plasma Protein Therapeutics Market Other Major And Innovative Companies

• Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG

38. Global Plasma Protein Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plasma Protein Therapeutics Market

40. Plasma Protein Therapeutics Market High Potential Countries, Segments and Strategies

• 40.1 Plasma Protein Therapeutics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Plasma Protein Therapeutics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Plasma Protein Therapeutics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer